C12N2710/20043 - CPC Classification Index

ClassID:

109958 ⎘

C12N2710/20043 - CPC Classification

Classification description:

dsDNA viruses; Details; Papillomaviridae; Use of virus, viral particle or viral elements as a vector viral genome or elements thereof as genetic vector

Recent Application in this class:

20250122260

2025-04-17

GLUCAGON-LIKE-PEPTIDE-2 (GLP-2) ANALOGUES

20230285533

2023-09-14

PROCESS FOR PRODUCING A PROPHYLACTIC AND THERAPEUTIC DNA IMMUNOLOGICAL COMPOSITION FOR HPV AND CANCERS ASSOCIATED WITH THE VIRUS, HYBRID PROTEIN, EXPRESSION VECTOR, IMMUNOLOGICAL COMPOSITION AND USES THEREOF

20210000937

2021-01-07

Parapoxvirus vectors

20200268869

2020-08-27

Mutant of L1 protein of human papillomavirus type 58

20200010850

2020-01-09

EFFICIENT CELL FREE PRODUCTION OF PAPILLOMAVIRUS GENE TRANSFER VECTORS

20170327543

2017-11-16

POLYIONIC PAPILLOMA VIRUS-LIKE PARTICLE (VLP) VACCINES

20150368314

2015-12-24

Method of treating stomach or bowel-related disorders by administering glucagon-like-peptide-2 (GLP-2) analogues

20140050753

2014-02-20

Polyionic papilloma virus-like particle (VLP) vaccines

20120289466

2012-11-15

Glucagon-like-peptide-2 (GLP-2) analogues

#10

20120225090

2012-09-06

METHODS FOR ENHANCING ANTIGEN-SPECIFIC IMMUNE RESPONSES

#11

20110223196

2011-09-15

HIV/SIV VACCINES FOR THE GENERATION OF MUCOSAL AND SYSTEMIC IMMUNITY

#12

20110152186

2011-06-23

Treatment of inflammatory bowel disease using glucagon-like-peptide-2 (GLP-2) analogues

#13

20110098222

2011-04-28

Glucagon-like-peptide-2 (GLP-2) analogues

#14

20110091496

2011-04-21

METHODS AND COMPOSITIONS FOR THE DELIVERY OF VACCINES TO DISRUPTED EPITHELIUM

#15

20100279416

2010-11-04

METHOD FOR INTRODUCING CHANGES INTO A EUKARYOTIC GENOME IN VIVO AND A KIT

#16

20100092504

2010-04-15

Combined human papillomavirus VLP/gene delivery system and use thereof as a vaccine for prophylaxis and immunotherapy of infectious diseases and tumors

#17